Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000538499 | SCV000644122 | likely pathogenic | Sengers syndrome | 2017-02-22 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 6 of the AGK gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with an AGK-related disease. In summary, donor and acceptor splice site variants are typically loss-of-function (PMID: 16199547), and loss-of-function variants in AGK are known to be pathogenic (PMID: 22284826). However, without additional functional and/or genetic data, this variant has been classified as Likely Pathogenic. |
Labcorp Genetics |
RCV005208714 | SCV001576431 | likely pathogenic | Sengers syndrome; Cataract 38 | 2017-02-06 | criteria provided, single submitter | clinical testing | In summary, donor and acceptor splice site variants are typically loss-of-function (PMID: 16199547), and loss-of-function variants in AGK are known to be pathogenic (PMID: 22284826). However, without additional functional and/or genetic data, this variant has been classified as Likely Pathogenic. This variant has not been reported in the literature in individuals with an AGK-related disease. This sequence change affects a donor splice site in intron 6 of the AGK gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. |